Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Cornberg

Showing results (181-190 of 350) with videos related to

Pageof 35
Sort By:
Hepatology (Baltimore, Md.)|December 31, 2013
Chronic hepatitis E virus infection beyond transplantation or human immunodeficiency virus infectionChristoph Höner zu Siederdissen, Sven Pischke, Jerome Schlue, et al.
European Journal of Immunology|June 15, 2016
Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapyJulia Hengst, Benedikt Strunz, Katja Deterding, et al.
BMC Gastroenterology|July 21, 2021
Antimicrobial resistance in patients with decompensated liver cirrhosis and bacterial infections in a tertiary center in Northern GermanyAnnika Hillert, Marie Schultalbers, Tammo L Tergast, et al.
Scientific Reports|September 30, 2025
T cell dysregulation reflects disease stage in hepatitis virus and alcohol-related liver diseaseChristian Niehaus, Yin-Han Chou, Helena Lickei, et al.
Journal of Leukocyte Biology|June 3, 2015
Altered effector functions of NK cells in chronic hepatitis C are associated with IFNL3 polymorphismMagdalena Rogalska-Taranta, Antoaneta A Markova, Andrzej Taranta, et al.
Clinical Nutrition (Edinburgh, Scotland)|June 23, 2024
Folic acid supplementation is associated with a decreased mortality and reduced hospital readmission in patients with decompensated alcohol-related liver cirrhosisLaura Buttler, Anja Tiede, Marie Griemsmann, et al.
Annals of Gastroenterology|November 3, 2018
A genotype-specific baseline score predicts post-treatment response to peginterferon alfa-2a in hepatitis B e antigen-negative chronic hepatitis BPietro Lampertico, Diethelm Messinger, Markus Cornberg, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 6, 2015
Eligibility and safety of the first interferon-free therapy against hepatitis C in a real-world settingChristoph Höner Zu Siederdissen, Benjamin Maasoumy, Katja Deterding, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 19, 2016
Treatment of HCV genotype 2 with sofosbuvir and ribavirin results in lower sustained virological response rates in real life than expected from clinical trialsFrank Tacke, Rainer Günther, Peter Buggisch, et al.
Journal of Hepatology|March 9, 2010
Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspectiveJerzy Jaroszewicz, Beatriz Calle Serrano, Karsten Wursthorn, et al.
Pageof 35

Showing results (181-190 of 350) with videos related to

Sort By:
Pageof 35
Hepatology (Baltimore, Md.)|December 31, 2013
Chronic hepatitis E virus infection beyond transplantation or human immunodeficiency virus infectionChristoph Höner zu Siederdissen, Sven Pischke, Jerome Schlue, et al.
European Journal of Immunology|June 15, 2016
Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapyJulia Hengst, Benedikt Strunz, Katja Deterding, et al.
BMC Gastroenterology|July 21, 2021
Antimicrobial resistance in patients with decompensated liver cirrhosis and bacterial infections in a tertiary center in Northern GermanyAnnika Hillert, Marie Schultalbers, Tammo L Tergast, et al.
Scientific Reports|September 30, 2025
T cell dysregulation reflects disease stage in hepatitis virus and alcohol-related liver diseaseChristian Niehaus, Yin-Han Chou, Helena Lickei, et al.
Journal of Leukocyte Biology|June 3, 2015
Altered effector functions of NK cells in chronic hepatitis C are associated with IFNL3 polymorphismMagdalena Rogalska-Taranta, Antoaneta A Markova, Andrzej Taranta, et al.
Clinical Nutrition (Edinburgh, Scotland)|June 23, 2024
Folic acid supplementation is associated with a decreased mortality and reduced hospital readmission in patients with decompensated alcohol-related liver cirrhosisLaura Buttler, Anja Tiede, Marie Griemsmann, et al.
Annals of Gastroenterology|November 3, 2018
A genotype-specific baseline score predicts post-treatment response to peginterferon alfa-2a in hepatitis B e antigen-negative chronic hepatitis BPietro Lampertico, Diethelm Messinger, Markus Cornberg, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 6, 2015
Eligibility and safety of the first interferon-free therapy against hepatitis C in a real-world settingChristoph Höner Zu Siederdissen, Benjamin Maasoumy, Katja Deterding, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 19, 2016
Treatment of HCV genotype 2 with sofosbuvir and ribavirin results in lower sustained virological response rates in real life than expected from clinical trialsFrank Tacke, Rainer Günther, Peter Buggisch, et al.
Journal of Hepatology|March 9, 2010
Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspectiveJerzy Jaroszewicz, Beatriz Calle Serrano, Karsten Wursthorn, et al.
Pageof 35